Cite
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.
MLA
Salhotra, Amandeep, et al. “Venetoclax and Hypomethylating Agents Yield High Response Rates and Favourable Transplant Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukaemia.” British Journal of Haematology, vol. 196, no. 6, Mar. 2022, pp. e71–74. EBSCOhost, https://doi.org/10.1111/bjh.17996.
APA
Salhotra, A., Tsai, N., Zhang, J., Ngo, D., Aribi, A., Sandhu, K., Ball, B., Al, M. M., Ali, H., Koller, P., Artz, A., Forman, S., Nakamura, R., Stein, A., Marcucci, G., Aldoss, I., & Pullarkat, V. (2022). Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia. British Journal of Haematology, 196(6), e71–e74. https://doi.org/10.1111/bjh.17996
Chicago
Salhotra, Amandeep, Ni‐Chun Tsai, Jianying Zhang, Dat Ngo, Ahmed Aribi, Karamjeet Sandhu, Brian Ball, et al. 2022. “Venetoclax and Hypomethylating Agents Yield High Response Rates and Favourable Transplant Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukaemia.” British Journal of Haematology 196 (6): e71–74. doi:10.1111/bjh.17996.